Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.7 USD -2.04% Market Closed
Market Cap: 285.1m USD

Wall Street
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
31% Upside
Average
Price Target
10.2 USD
32% Upside
Highest
Price Target
10.5 USD
36% Upside
Lifecore Biomedical Inc Competitors:
Price Targets
AKBM
Aker Biomarine ASA
2% Downside
1497
Xiamen Yan Palace Bird's Nest Industry Co Ltd
0% Upside
WWL
Wawel SA
4% Downside
300999
Yihai Kerry Arawana Holdings Co Ltd
11% Upside
TKN
Taokaenoi Food & Marketing PCL
33% Upside
KRI
Kri Kri Milk Industry SA
7% Downside

Revenue
Forecast

Revenue Estimate
Lifecore Biomedical Inc

For the last 13 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 12%.

-7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFCR's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 12%.

Back to Top